Pharmaceutical Industry

CommentaryHere are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
By Jeffrey Sonnenfeld and Steven TianOctober 10, 2024

HealthMost Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
By Lindsey LeakeOctober 10, 2024

By AFPOctober 10, 2024

CommentarySome businesses are now backtracking on DEI. Biopharma cannot afford to and must remain resolute
By Robert BlumOctober 9, 2024

PoliticsMartin Shkreli gets snubbed by the Supreme Court and must return millions he reaped from jacking up the price of a lifesaving drug
By Lindsay Whitehurst and The Associated PressOctober 7, 2024

TechGoogle DeepMind exec says AI will increase efficiency so much it’s expected to handle 50% of info requests in its legal department
By Paolo ConfinoOctober 7, 2024

By Greg McKennaOctober 7, 2024

By Ashleigh Furlong and BloombergOctober 4, 2024

By Beth GreenfieldOctober 2, 2024

By Ryan HoggSeptember 24, 2024

FinanceNovo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
By Sara Sjolin, Sanne Wass, Oliver Crook and BloombergSeptember 23, 2024

By Lindsey LeakeSeptember 21, 2024

LeadershipMark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
By Sydney LakeSeptember 16, 2024
Most Popular




